Feedback / Questions
AFNT-111 - Affini-T Therap
Undisclosed HLA-A02 TP53-R175H targeting TCE - Affini-T Therap
AFNT-211 - Affini-T Therap
https://affinittx.com/press-releases/affini-t-therapeutics-presents-preclinical-data-from-its-programs-targeting-oncogenic-drivers-kras-and-tp53-at-aacr/
Apr 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next